BRIEF-Opiant Pharmaceuticals Q3 earnings per share $0.15

* Opiant pharmaceuticals, inc. Reports fiscal third quarter 2016 financial results and provides corporate update
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.